Abnormal behavior
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
910
|
121
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2019 |
Encephalomyelitis
|
disease |
Infections; Nervous System Diseases
|
Disease or Syndrome
|
865
|
7
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
853
|
42
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Mental disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
789
|
149
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Memory impairment
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
763
|
48
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2018 |
Malignant neoplasm of soft tissue
|
group |
Neoplasms
|
Neoplastic Process
|
699
|
32
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Amyloidosis
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
694
|
93
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Subarachnoid Hemorrhage
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
501
|
26
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Fibrosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
413
|
9
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Cardiac Arrest
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
411
|
50
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Adult Fibrosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
387
|
9
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Macrocephaly
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Congenital Abnormality
|
367
|
10
|
0.100 |
None |
|
0 |
|
|
|
Pervasive Development Disorder
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
328
|
49
|
0.020 |
None |
1.000 |
2 |
1
|
2013 |
2015 |
Frontotemporal dementia
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
320
|
215
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
CNS disorder
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
319
|
11
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
282
|
21
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Well Differentiated Oligodendroglioma
|
disease |
Neoplasms
|
Neoplastic Process
|
270
|
22
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Malignant Peripheral Nerve Sheath Tumor
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
261
|
19
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Autistic behavior
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
261
|
78
|
0.100 |
None |
|
0 |
|
|
|
Moderate intellectual disability
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
251
|
94
|
0.010 |
None |
1.000 |
1 |
|
1997 |
1997 |
Senile Plaques
|
disease |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
249
|
21
|
0.010 |
None |
1.000 |
1 |
|
1996 |
1996 |